Anna Bornefalk‐Hermansson

Author

Uppsala University ORCID

Also Known As

A. Bornefalk-Hermansson, Anna Bornefalk Hermansson, Anna Bornefalk-Hermansson, Anna Bornefalk‐Hermansson

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Lund University Örebro University Uppsala University Hospital Umeå University

About

Anna Bornefalk‐Hermansson is an author at Uppsala University specializing in medicine, pulmonary medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	248
2	Engineering	2	2	63
3	Management	1	1	26
4	Natural Sciences	1	1	37
5	Biostatistics	1	1	37

Anna Bornefalk‐Hermansson

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study Magnus Ekström, Anna Bornefalk‐Hermansson, Amy P. Abernethy, BMJ	2014	295
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial Torsten Sandberg, Gunilla Skoog, Anna Bornefalk‐Hermansson, The Lancet UrologyAntibioticsAntimicrobial StewardshipAcute PyelonephritisSepsis	2012	185
Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease Magnus Ekström, Anna Bornefalk‐Hermansson, Kerstin Ström American Journal of Respiratory and Critical Care Medicine	2013	155
Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study Zainab Ahmadi, Anna Bornefalk‐Hermansson, Karl A. Franklin, Respiratory Research	2014	72
The identification of complex interactions in epidemiology and toxicology: a simulation study of boosted regression trees Erik Lampa, Lars Lind, Peter Lind, Environmental Health	2014	58
Long-Term Oxygen Therapy 24 vs 15 h/day and Mortality in Chronic Obstructive Pulmonary Disease Zainab Ahmadi, Josefin Sundh, Anna Bornefalk‐Hermansson, PLoS ONE Pulmonary CareAdvanced Lung DiseaseRespiratory TherapyLtot 15Ltot 24	2016	53
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease Magnus Ekström, Hans Bornefalk, C. Magnus Sköld, Journal of Pain and Symptom Management	2020	48
Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada? Nina Johnston, Anna Bornefalk‐Hermansson, Karin Schenck‐Gustafsson, European Heart Journal Acute Cardiovascular Care	2013	47
On the comparison of FROC curves in mammography CAD systems Hans Bornefalk, Anna Bornefalk‐Hermansson Medical Physics EngineeringMachine LearningFeature DetectionBiometricsConfidence Interval	2005	37
Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease Magnus Ekström, Hans Bornefalk, Magnus Sköld, BMJ Open Respiratory Research	2019	35

Page 1